drugset / Trial / NCT00579046
Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the impact of erythropoietin treatment of anemia on exercise capacity of patients with chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2008-11
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 10 ug/ml | — |
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 15 ug/ml | — |
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 20 ug/ml | — |
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 30 ug/ml | — |
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 40 ug/ml | — |
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 50 ug/ml | — |
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 60 ug/ml | — |
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 80 ug/ml | — |
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 100 ug/ml | — |
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 150 ug/ml | — |
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 300 ug/ml | — |